Skip to Content
Søg Menu

Lungecancer

”One-size-fits-all”-tilgang gælder ikke længere blærecancerbehandling

/ Amanda Feldballe Bernholm
Blærecancer
Alison J Birtle

One-Size-Fits-All No Longer Applies in Bladder Cancer Care

/ Alison Birtle
Blærecancer Play the Video

Highlights From the Nordic Urothelial Cancer Oncology Group (NUCOG)

/ Katrine Ørum / Helle Pappot / Anders Ullén
Blærecancer
Dag Stormoen

Immunterapi og antibody-drug conjugates vil få en central plads i fremtidens behandling af blærecancer

/ Dag Rune Stormoen
ASCOGU25Blærecancer Play the Video
Thomas Powles

Bladder Cancer Treatment Advancements: Key Findings and Progress

/ Thomas Powles
ASCOGU25Blærecancer Play the Video

Real-Life Data Confirms Avelumab Maintenance Benefits in Metastatic Urothelial Carcinoma

/ Deniz Tural / Jan Andreasen
ASCOGU25Blærecancer
Petros Grivas

Bladder Cancer: Avelumab Maintenance Shows Benefit for Both Patients With and Without Diabetes Mellitus

/ Petros Grivas
ASCOGU25Type 2-diabetesBlærecancer Play the Video
Peter J. Goebell

Real-World Effectiveness of Avelumab in First-Line Maintenance for Bladder Cancer

/ Peter J. Goebell
ASCOGU25Blærecancer Play the Video
Helen Moon

Influence of Tumor Burden on Treatment Strategies and Clinical Outcomes in LA/mUC Patients Receiving Avelumab First-Line Maintenance: Insights from Real-World Data

/ Helen Moon
ASCOGU25Blærecancer Play the Video

Bivirkninger ved behandling af metastatisk blærecancer med EV+pembrolizumab

/ Jan Andreasen / Andreas Carus
Blærecancer
Interview With Thomas Powles

Maximizing the Tolerability of Enfortumab Vedotin + Pembrolizumab – The Upcoming New Standard Treatment for Advanced Bladder Cancer

/ Thomas Powles
Blærecancer Play the Video

Norwegian Perspectives on Urogenital Cancer at ESMO 2024

/ BestPractice Nordic
ESMO24ProstatacancerNyrecancerBlærecancer
Hent flere
Back to top